Chris J. McNeil

Chris J. McNeil

Auto-generated profile, based on publicly available information

Chris J. McNeil

Aberdeen Biomedical Imaging Centre, Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen, UK

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2001 in The Journal of Nutrition
Verified
Journal Article
Open access
PDF file
GLGerald E. Lobley
Gerald E. Lobley
SHSimone O. Hoskin
Simone O. Hoskin
CMChris J. McNeil
Chris J. McNeil
With its many proposed metabolic roles, glutamine would seem to have major potential in normal animal production systems as well as during situations involving adverse challenges. In practice, however, responses to glutamine supplementation have been inconsistent. Thus, during lactation and growth studies in ruminants, both positive and null effects on production responses have been reported. Similarly, therapeutic responses to glutamine supplementation during various digestive tract disorders have been inconsistent in both pigs and ruminants. This is despite a proven involvement in the nucleic acid biosynthesis necessary to support cell proliferation. In sheep, at least, glutamine may exert a protective effect against hepatic amino acid (AA) oxidation, particularly for methionine. This may offer anabolic potential because methionine is the first limiting AA in a number of animal feedstuffs. Glutamine is also important in control of metabolic acidosis, but, in contrast to rodents, the main site of production seems to be extra-hepatic. In the immune system, while lymphocyte proliferation is glutamine-dependent, intracellular concentrations are low (in contrast to other tissues, such as muscle and liver). Instead, glutamate is accumulated, but the majority of this (∼65%) is derived in vivo from plasma glutamine. In sheep, endotoxin challenge elevates the plasma flux of glutamine, with a corresponding decrease in plasma concentration. At the same time, both the glutamate accumulation and fractional rate of protein synthesis within lymphocytes are enhanced. These lymphocyte responses, however, are not altered by an AA supplement that contains glutamine. Overall, although glutamine obviously plays important metabolic roles within the body, supplementation does not appear to provide consistent beneficial or therapeutic effects, except during certain catabolic situations. Glutamine availability, therefore, does not seem to be a limitation in many challenge situations. Rather, glutamine may signal alterations in nutrient demands among organs and a better understanding of this role may increase understanding of where modulation of glutamine status would be beneficial.

16 November 2017 in Geriatrics
Verified
Journal Article
Open access
PDF file
MKMina Khezrian
Mina Khezrian
Phyo MyintPhyo Myint
Phyo Myint
CMChristopher McNeil
Christopher McNeil
AMAlison D. Murray
Alison D. Murray
Background: Frailty, a very important complication of increasing age, is a well-recognised concept although it has not been accurately measured in the clinical setting. The aim of this literature review is to summarise commonly used frailty screening tools, and to describe how new measurement methods have been developed recently. Methods: Several frailty measurement tools including the most cited and newly developed scales have been described in this review. We searched the MEDLINE using the search terms; “frailty score, scale, tool, instrument, index, phenotype” and then summarised selected tools for physical, cognitive, emotional and co-morbidity domains. Results: The most cited frailty measurement methods developed from 1999 to 2005 are primarily criteria for physical frailty (e.g., frailty phenotype). More recently developed tools (e.g., triad of impairment and multidimensional frailty score) consider cognitive and emotional domains in addition to physical deficit in measuring frailty. Co-morbidity has also been considered as a domain of frailty in several measurement tools. Conclusion: Although frailty tools have traditionally assessed physical capability, cognitive and emotional impairment often co-exist in older adults and may have shared origins. Therefore, newer tools which provide a composite measure of frailty may be more relevant for future use.

1 October 2014 in NeuroImage
Verified
Journal Article
Closed access
ASAnca-Larisa Sandu
Anca-Larisa Sandu
RSRoger T. Staff
Roger T. Staff
CMChris J. McNeil
Chris J. McNeil
NMNazahah Mustafa
Nazahah Mustafa
TATrevor Ahearn
Trevor Ahearn
AMAlison D. Murray
Alison D. Murray

1 April 2007 in Domestic Animal Endocrinology
Verified
Journal Article
Closed access
RTR.E. Tilley
R.E. Tilley
CMC.J. McNeil
C.J. McNeil
CAC.J. Ashworth
C.J. Ashworth
KPK.R. Page
K.R. Page
HMH.J. McArdle
H.J. McArdle

4 July 2012 in Molecular Nutrition & Food Research
Verified
Journal Article
Open access
PDF file
JBJohn H. Beattie
John H. Beattie
MGMargaret‐Jane Gordon
Margaret‐Jane Gordon
SDSusan J. Duthie
Susan J. Duthie
CMChris J. McNeil
Chris J. McNeil
GHGraham W. Horgan
Graham W. Horgan
IKIn‐Sook Kwun
In‐Sook Kwun
Scope: Cardiovascular health is strongly influenced by diet. Zinc has antioxidant and anti‐inflammatory properties but its long‐term influence on vascular health at dietary intake levels relevant to the human population in developed countries has not been studied. We investigated the influence of suboptimal zinc intake in a Western‐type diet on the development of vascular inflammation and arterial plaque in apoE knock‐out (AEKO) mice.Methods and results: Weanling AEKO and wild‐type (WT) controls were given high saturated fat (21% w/w) and high cholesterol (0.15%) semi‐synthetic diets containing 3 or 35 mg Zn/kg (AEKO and WT) or 8 mg Zn/kg (AEKO only) for over 6 months. AEKO mice on zinc intakes of 3 and 8 mg Zn/kg (suboptimal zinc) developed significantly (p < 0.05) more aortic plaque than AEKO mice consuming 35 mg Zn/kg (adequate zinc). Circulating levels of interleukin‐1β, interleukin‐6 and soluble vascular adhesion molecule‐1 were significantly (p < 0.05) raised at the lowest zinc intake in AEKO mice, as compared to zinc‐adequate controls. Plasma total cholesterol and total protein were also significantly (p < 0.05) increased at the lowest zinc intake.Conclusion: We propose that suboptimal dietary zinc intake raises circulating pro‐atherogenic lipoprotein levels that promote vascular inflammation and enhance arterial plaque formation.

22 March 2011 in AGE
Verified
Journal Article
Closed access
PDF file
AMAlison D. Murray
Alison D. Murray
RSRoger T. Staff
Roger T. Staff
CMChris J. McNeil
Chris J. McNeil
SSSima Salarirad
Sima Salarirad
JSJohn M. Starr
John M. Starr
LWLawrence J. Whalley
Lawrence J. Whalley